A. C. Andreotti

Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects

Roberto Lanzi, Livio Luzi, Andrea Caumo et al. · Metabolism · 1999 · 88 citations

Obesity, Metabolic Syndrome, Growth Hormone +11

Pharmacokinetics, pharmacodynamics, and tolerability of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0, and 1.5 milligrams) in healthy male volunteers.

A. C. Andreotti, E. Pianezzola, Stefano Persiani et al. · The Journal of Clinical Endocrinology & Metabolism · 1995 · 46 citations

Hypertension, Prl Secretion Areas, Pharmacological Study +11

Acute pharmacologic blockade of lipolysis normalizes nocturnal growth hormone levels and pulsatility in obese subjects

A. C. Andreotti, Roberto Lanzi, M. Manzoni et al. · Metabolism · 1994 · 37 citations

Obesity, Metabolic Syndrome, Growth Hormone +10

Evidence for an Inhibitory Effect of Physiological Levels of Insulin on the Growth Hormone (GH) Response to GH-Releasing Hormone in Healthy Subjects

Roberto Lanzi, M. Manzoni, A. C. Andreotti et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 22 citations · Full text

Acipimox Enhances, Healthy Subjects, Oral Acipimox Administration +16

Pharmacokinetics, pharmacodynamics, and tolerability of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0, and 1.5 milligrams) in healthy male volunteers

A. C. Andreotti · The Journal of Clinical Endocrinology & Metabolism · 1995 · 13 citations

Pharmacological Study, Healthy Male Volunteers, Pharmacology +6